Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/Naloxone vs Codeine/Paracetamol for Chronic Hip/Knee Osteoarthritis Pain
2012-004796-39Phase 4Terminated
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone and paracetamol + caffeine in knee osteoarthritis (OA), hip osteoarthritis and chronic pain (2 arms), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Efficacy and tolerability comparison. Started Apr 2013; status: terminated.
02
Drugs
oxycodoneparacetamol + caffeine
03
Conditions
knee osteoarthritis (OA)hip osteoarthritischronic pain
Beyond the preview
Go deeper on 2012-004796-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004796-39.